Clinical Trials Logo

Filter by:
NCT ID: NCT06423794 Enrolling by invitation - Bipolar Disorder Clinical Trials

BHV-7000 Open-Label Extension Bipolar Mania Study

Start date: June 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

NCT ID: NCT06422273 Enrolling by invitation - Clinical trials for Lung Transplant; Complications

Protest Trial: TXA vs Saline

Start date: April 16, 2024
Phase: Phase 3
Study type: Interventional

To determine if endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients reduces bleeding risk.

NCT ID: NCT06420297 Enrolling by invitation - Clinical trials for Hyperphagia in Prader-Willi Syndrome

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Start date: March 11, 2024
Phase: Phase 3
Study type: Interventional

To evaluate long-term safety and tolerability of carbetocin nasal spray (3.2 mg TID) in subjects with PWS

NCT ID: NCT06417684 Enrolling by invitation - Vestibular Migraine Clinical Trials

Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine

RCTVM
Start date: June 19, 2024
Phase: Early Phase 1
Study type: Interventional

Vestibular migraine (VM) is one of the most common causes of vertigo attacks, affecting 1 - 5% of people. People with vestibular migraine have lower quality of life compared to others and some may experience completely debilitating symptoms. Symptoms include vertigo, nausea, head motion-induced dizziness, unsteadiness, balance problems, and lightheadedness. There is evidence the medication amitriptyline in isolation and also our lifestyle modification intervention in isolation can each help reduce symptoms of dizziness and headache in patients with VM. However, these data are observational and subject to various types of bias. The purpose of the current investigation is to determine outcomes from each intervention using randomized allocation of participants diagnosed with VM into either the amitriptyline arm or the lifestyle modification arm. The investigators will measure for change in dizziness using the Dizziness Handicap Inventory (DHI) and for change in headache using the Headache Disability Inventory (HDI). For participants in the lifestyle modification arm, the investigators will also measure for change in lifestyle factor to determine improvement on those intervention factors. Measures will be obtained pre-intervention to establish baseline, at 30 days, 60 days, and 90 days. the investigators will also re-survey participants one year after initiation of intervention to determine adherence and status.

NCT ID: NCT06416072 Enrolling by invitation - Clinical trials for Preclinical Alzheimer's Disease

Alzheimer's Plasma Extension

APEX
Start date: September 21, 2023
Phase:
Study type: Observational

The APEX study is a multicenter, observational study designed to capture longitudinal follow-up of plasma biomarkers and cognitive and functional assessments on individuals who screen failed in the AHEAD study over approximately 4 years. Approximately 1000 participants will be enrolled across three groups: - Group A: Approximately 500 participants who are discordant on screening (plasma positive / Positron Emission Tomography (PET) negative), - Group B: Approximately 250 participants who are concordant on screening (plasma negative / PET negative), and - Group C: Approximately 250 participants selected from the individuals who previously screen failed prior to PET for the AHEAD study with oversampling of racial and ethnic populations underrepresented in Alzheimer's disease (AD) clinical trials. Primary Objectives: - Collect longitudinal cognitive and functional assessments and blood-based biomarker data - Evaluate, characterize, and compare the longitudinal cognitive and functional data between the three groups of participants - Compare longitudinal change across race and ethnicity, sex, and Apolipoprotein E (ApoE) status Exploratory Objectives: • Collect baseline amyloid PET on participants without prior amyloid PET data (Group C)

NCT ID: NCT06415994 Enrolling by invitation - Pregnancy Related Clinical Trials

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

Start date: February 13, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about the long term effects of prenatal opioid exposure. The main objectives are: - Long term goal: to improve the safety and efficacy of maternal Opioid Use Disorder (OUD) and eliminate neonatal opioid withdrawal syndrome (NOWS) and poor childhood neurodevelopment. - To characterize prenatal opioid exposure (POE) related placental and fetal brain structural and functional disruptions using longitudinal placenta-fetal brain magnetic resonance imaging (MRI) and determine proteomic, genomic, and epigenetic signatures of NOWS and poor infant neurodevelopment. In this study participants will: - Receive two placental-fetal MRIs, one during second trimester and one in third trimester. - Answer surveys relating to their medical and social history. - Have blood drawn during pregnancy and delivery. - Child development follow up: answer surveys on their child's development milestones and at one year of life they will undergo a development assessment.

NCT ID: NCT06415760 Enrolling by invitation - Coagulation Clinical Trials

Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients

Start date: May 7, 2024
Phase:
Study type: Observational

This study will determine reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge in the last trimester of non-laboring pregnant women with an uncomplicated pregnancy

NCT ID: NCT06415136 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Adjacent Level Anterior Cervical Fusion: SeaSpine Shoreline Versus Removal of Previously Implanted Plate and Replating

Start date: May 5, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate the efficacy of SeaSpine Shoreline device in surgery of the cervical spine.

NCT ID: NCT06415123 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Study to Assess the Performance of MagnEtOs Flex Matrix Compared to Cellular Allograft

Start date: May 2024
Phase:
Study type: Observational

The purpose of this study is to demonstrate the performance of MagnetOs Flex Matrix in patients with leg pain and/or back pain.

NCT ID: NCT06415110 Enrolling by invitation - Clinical trials for Spondylolisthesis, Grade 1

A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion

Start date: May 2024
Phase:
Study type: Observational

The purpose of this study is to assess the radiographic and clinical outcomes of spinal fusion following use of Allosync Expand and autograft bone graft.